- Home
- TPB vs ORKA Comparison
TPB vs ORKA Comparison
Compare TPB & ORKA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TPB
- ORKA
- Stock Information
- Founded
- TPB 1988
- ORKA 2004
- Country
- TPB United States
- ORKA United States
- Employees
- TPB N/A
- ORKA N/A
- Industry
- TPB Tobacco
- ORKA Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- TPB Consumer Discretionary
- ORKA Health Care
- Exchange
- TPB Nasdaq
- ORKA Nasdaq
- Market Cap
- TPB 1.1B
- ORKA 1.0B
- IPO Year
- TPB 2016
- ORKA N/A
- Fundamental
- Price
- TPB $59.25
- ORKA $20.31
- Analyst Decision
- TPB Strong Buy
- ORKA Strong Buy
- Analyst Count
- TPB 4
- ORKA 6
- Target Price
- TPB $68.75
- ORKA $43.60
- AVG Volume (30 Days)
- TPB 211.9K
- ORKA 387.6K
- Earning Date
- TPB 11-07-2024
- ORKA 02-15-2025
- Dividend Yield
- TPB 0.47%
- ORKA N/A
- EPS Growth
- TPB 283.79
- ORKA N/A
- EPS
- TPB 2.48
- ORKA N/A
- Revenue
- TPB $409,407,000.00
- ORKA N/A
- Revenue This Year
- TPB $3.01
- ORKA N/A
- Revenue Next Year
- TPB $2.26
- ORKA N/A
- P/E Ratio
- TPB $23.87
- ORKA N/A
- Revenue Growth
- TPB 0.28
- ORKA N/A
- 52 Week Low
- TPB $21.98
- ORKA $18.20
- 52 Week High
- TPB $66.18
- ORKA $53.88
- Technical
- Relative Strength Index (RSI)
- TPB 49.85
- ORKA N/A
- Support Level
- TPB $58.16
- ORKA N/A
- Resistance Level
- TPB $64.87
- ORKA N/A
- Average True Range (ATR)
- TPB 2.44
- ORKA 0.00
- MACD
- TPB -1.03
- ORKA 0.00
- Stochastic Oscillator
- TPB 22.96
- ORKA 0.00
About TPB Turning Point Brands Inc.
Turning Point Brands Inc operates as manufacturer, marketer, provider of consumer products that include Other Tobacco Products (OTP) in the U.S. The company offers a wide variety across the OTP spectrum including moist snuff tobacco (MST), loose-leaf chewing tobacco, premium cigarette papers, make- your-own (MYO) cigar wraps, cigars, liquid vapor products, and tobacco vaporizer products. It operates in three segments namely Zig-Zag products; Stoker's products and NewGen products. The company generates maximum revenue from the Zig-Zag products segment.
About ORKA Oruka Therapeutics Inc. Common Stock
Oruka Therapeutics Inc is developing novel biologics designed to set a new standard for the treatment of chronic skin diseases. It is to offer patients suffering from chronic skin diseases like plaque psoriasis.